Skip to main content

Table 1 Baseline characteristics of individuals in the test set. Continuous variables are reported as mean (sd) and for categorical variables absolute numbers and percentages are given

From: The roles of predictors in cardiovascular risk models - a question of modeling culture?

 

Test set

(n = 514,661)

Men

(n = 237,748; 46.2%)

Women

(n = 276,913; 53.8%)

Age (years)

49.9 (11.9)

50.1 (12.2)

Total cholesterol (mg/dl)

210 (41.9)

212 (41.6)

HDL cholesterol (mg/dl)

51.4 (14.9)

63.9 (17.2)

Cholesterol ratio (total cholesterol/HDL cholesterol)

4.38 (1.43)

3.54 (1.14)

Triglycerides (mg/dl)

146 (94.6)

108 (62.3)

Blood glucose (mg/dl)

98.3 (24.7)

92.7 (20.4)

Systolic BP (mmHg)

133 (17.3)

127 (18.7)

Diastolic BP (mmHg)

82.7 (10.1)

79.6 (10.4)

BP classes

 Ideal

25,964 (11.0%)

67,687 (24.4%)

 Normal

59,743 (25.1%)

74,538 (26.9%)

 Still normal

55,766 (23.5%)

52,224 (18.9%)

 Hypertension stage 1

56,417 (23.7%)

45,370 (16.4%)

 Hypertension stage 2

7200 (3.0%)

6264 (2.3%)

 Isolated systolic hypertension

32,658 (13.7%)

30,830 (11.1%)

Hypertensive drug intake

 Yes (vs. no)

32,731 (13.8%)

34,987 (12.6%)

Smoking status

 Yes (vs. no)

59,279 (24.9%)

58,164 (21.0%)

Diabetes

 Yes (vs. no)

13,688 (5.8%)

11,006 (4.0%)

BMI score (kg/m2)

27.4 (4.69)

26.0 (5.68)

BMI classes

 < 18.5

866 (0.4%)

6546 (2.4%)

 18.5–24.9

75,942 (31.9%)

136,837 (49.4%)

 25.0–29.9

108,615 (45.7%)

78,301 (28.3%)

 30.0–34.9

37,675 (15.8%)

34,310 (12.4%)

 35.0–39.9

8229 (3.5%)

11,454 (4.1%)

 ≥ 40.0

6421 (2.7%)

9465 (3.4%)

Waist circumference

 Too large (vs. okay)

83,503 (35.1%)

96,416 (34.8%)

Physical activity

 None

26,347 (11.1%)

31,161 (11.3%)

 Ocassionally

101,706 (42.8%)

118,890 (42.9%)

 Regularly

109,695 (46.1%)

126,862 (45.8%)

Protein in urine

 Positive (vs. negative)

14,403 (6.1%)

16,267 (5.9%)

Glucose in urine

 Positive (vs. negative)

5481 (2.3%)

4294 (1.6%)

  1. Abbreviations: BMI body mass index, BP blood pressure, HDL high density lipoprotein